Understanding the Risks of Investing in Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc’s recent filing unveils that its Director FRIEDMAN PAUL A unloaded Company’s shares for reported $6.47 million on Apr 08 ’24. In the deal valued at $246.19 per share,26,270 shares were sold. As a result of this transaction, FRIEDMAN PAUL A now holds 185,735 shares worth roughly $43.27 million. Then, Taub Rebecca sold […]

A Guide To The Risks Of Investing In Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc’s recently made public that its Director FRIEDMAN PAUL A unloaded Company’s shares for reported $6.72 million on Apr 05 ’24. In the deal valued at $243.40 per share,27,613 shares were sold. As a result of this transaction, FRIEDMAN PAUL A now holds 185,735 shares worth roughly $46.31 million. Then, Taub Rebecca sold […]

Insider Sale Alert: Madrigal Pharmaceuticals Inc [MDGL] – Is it Time to sell?

Madrigal Pharmaceuticals Inc’s filing revealed that its Senior VP, Chief Pharma Dev. Waltermire Robert E. unloaded Company’s shares for reported $0.48 million on Dec 15 ’23. In the deal valued at $238.50 per share,2,000 shares were sold. As a result of this transaction, Waltermire Robert E. now holds 5,667 shares worth roughly $1.45 million. Then, […]

Do Investors Have Much Faith In Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL)

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) does about 630.57K shares in volume on a normal day but saw 614901 shares change hands in Friday trading. The company now has a market cap of 5.23B USD. Its current market price is $303.39, marking an increase of 2.83% compared to the previous close of $295.04. The 52 week high […]